Tag Archive for: Conference

Gudrun Vogtentanz, Chief Scientific Officer at AMSilk, to speak at the Rethinking Materials Summit, 14 May 2024

/in

NEURIED, Germany, May 2, 2024 – AMSilk GmbH (“AMSilk”), a frontrunner in advanced biomaterials made from spider silk-based proteins, today announces that Gudrun Vogtentanz, Chief Scientific Officer, will participate in a panel discussion titled ‘Advancing the Bioeconomy: Plant-Based Specialty Chemicals and Bio-Based Building Block Molecules’ at the Rethinking Materials Summit in London on the 14th of May at 17:15. AMSilk’s […]

Read more

Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium

/in

Two key presentations by leading KOLs highlight positive results from aXess trials in adult patients with end-stage renal disease who need vascular access to hemodialysis aXess is a restorative arteriovenous dialysis conduit which allows vascular access for hemodialysis through the creation of a new, long-term living vessel EINDHOVEN, The Netherlands, 17 April 2024 – Xeltis, […]

Read more

JPM ’24: The year’s healthcare barometer gives a more sunny outlook

/in

The JPM Healthcare Conference of 2024 may not have witnessed a mega-merger announcement, but there is anticipation that the M&A market could pick up this year, with predictions that the economic headwinds of recent years could turn into tailwinds.  The recent M&A Firepower report from EY, formerly known as Ernst & Young, has forecast a […]

Read more

IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting

/in

Non-clinical data demonstrate clear impact of immune modulating vaccines targeting IDO1 and PD-L1 on several tumoral immune escape mechanisms in the tumor microenvironment (TME) leading to enhanced anti-tumor effect NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating cancer vaccines based on its T-win® technology […]

Read more